Thanks for checking eieio. No wonder the interest is always with siRNA, when even the research papers don't seem to highlight the difference between siRNA and ddRNAi. I'm just amazed that Peter French didn't insist on clarification.
- Forums
- ASX - By Stock
- BLT
- Ann: EFFICACY IN TRANSPLANT REJECTION
Ann: EFFICACY IN TRANSPLANT REJECTION , page-13
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online